Journal Articles   |   Book chapters   |   Technical Reports

Journal Articles

Cost and Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Two Hospitals of Thailand

C. Suraratdecha, R. Stuart, C. Manopaiboon, D. Green, C. Lertpiriyasuwat, D. Wilson, P. Pavaputanon, P. Visavakum, P. Monkongdee, T. Khawcharoenporn, P. Tharee, C. Kittinunvorakoon, M. Martin. (2018)

J Int AIDS Society, In Press

Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions

R. Pearson, M. Killedar, J. Petravic, J.J Kakietek, N. Scott, K.L. Grantham, R.M. Stuart, D.J. Kedziora, C. Kerr, J. Skordis-Worrall, M. Shekar, D.P. Wilson (2018)

BMC Public Health, 18(1):384 [PDF]

How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries

R.M. Stuart, L. Grobicki, H. Haghparast-Bidgoli, J. Skordis-Worrall, O. Keiser, J. Estill, Z. Baranczuk, J. Panovska-Griffiths, S.L. Kelly, I. Reporter, D.J. Kedziora, A.J. Shattock, J. Petravic, S.A. Hussain, K.L. Grantham, R.T. Gray, X.F. Yap, R. Martin-Hughes, C.J. Benedikt, N. Fraser-Hurt, E. Masaki, D.J. Wilson, M. Gorgens, E. Mziray, N. Cheikh, Z. Shubber, C.C. Kerr, D.P. Wilson. (2018)

J Int AIDS Society, 21:e25097 [PDF]

The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS

S.L. Kelly, R. Martin-Hughes, R.M Stuart, X.F. Yap, D.J. Kedziora, K.L. Grantham, S.A. Hussain, I. Reporter, A.J. Shattock, L. Grobicki, H. Haghparast-Bidgoli, J. Skordis-Worrall, Z. Baranczuk, O. Keiser, J. Estill, J. Petravic, R.T. Gray, C.J. Benedikt, N. Fraser, M. Gorgens, D. Wilson, C.C. Kerr, D.P. Wilson. (2018)

Lancet HIV, 5(4):e190-e198 [PDF]

Optimization by Adaptive Stochastic Descent

C.C. Kerr, S. Dura-Bernal, T.G. Smolinski, G.L. Chadderdon, D.P. Wilson. (2018)

PLoS One13(3), e0192944 [PDF]

The City of Johannesburg can end AIDS by 2030: modeling the impact of achieving the fast-track targets and what it will take to get there

R.M. Stuart, N. Fraser-Hurt, C.C. Kerr, E. Mabusela, V. Madi, F. Mkhwanazi, Y. Pillay, P. Barron, B. Muzah, T. Matsebula, M. Gorgens, D.P. Wilson. (2018).

J Int AIDS Society, 21:e25068 [PDF]

Getting it right when budgets are tight: using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics

R.M. Stuart, C.C. Kerr, H. Haghparast-Bidgoli, J. Estill, L. Grobicki, Z. Baranczuk, L. Prieto, V. Montañez, I. Reporter, R.T. Gray, J. Skordis-Worrall, O. Keiser, N. Cheikh, K. Boonto, S. Osornprasop, F. Lavadenz, C.J. Benedikt, R. Martin-Hughes, A. Hussain, S.L. Kelly, D.J. Kedziora, D.P. Wilson. (2017)

PLoS One, 12(10):e0185077 [PDF]

Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations

N. Scott, S.A. Hussain, R. Martin-Hughes, F.J.I. Fowkes, C.C. Kerr, R. Pearson, D.J. Kedziora, M. Killedar, R.M. Stuart, D.P. Wilson. (2017)

Malaria Journal, 16:368 [PDF]

Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok

E.D.M.B. Kroon, N. Phanuphak, A.J. Shattock, J.L.K. Fletcher, S. Pinyakorn, N. Chomchey, S. Akapirat, M.S. de Souza, M.L. Robb, J.H. Kim, F. van Griensven, J. Ananworanich, D.P. Wilson on behalf of the RV254/SEARCH 010 Study Group. (2017)

J Int AIDS Society, 20:21708 [PDF]

Kazakhstan can achieve ambitious HIV targets by combining improved ART procurement mechanisms with allocative and implementation efficiencies

A.J. Shattock, C. Benedikt, A. Bokazhanova, P. Đurić, I. Petrenko, L. Ganina, S.L. Kelly, R.M. Stuart, C.C. Kerr, T. Vinichenko, S. Zhang, C. Hamelmann, M. Manova, E. Masaki, D.P. Wilson, R.T. Gray. (2016)

PLoS One, 12(2) [PDF]

Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs

C. Benedikt, S.L. Kelly, D. Wilson, D.P. Wilson on behalf of the Optima Consortium. (2016)

Int J Drug Policy, 38:73-80 [PDF]

GBD 2015 and HIV estimates from the Optima model

S. Kelly, D.P. Wilson. (2016)

The Lancet HIV, 3(12):e558 [PDF]

Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programs for seasonal migrant laborers.

S.L. Kelly, A.J. Shattock, C.C. Kerr, R.M. Stuart, A. Papoyan, T. Grigoryan, R. Hovhannisyan, S. Grigoryan, C. Benedikt, D.P. Wilson. (2016).

J Int AIDS Society, 19:20772 [PDF]

A no-brainer for ending AIDS: the case for a harm reduction decade

Cook C, Lines R, Wilson DP (2016)

J Int AIDS Society, 19:21129 [PDF]

Local responses to local epidemics for national impact need advanced spatially-explicit tools

K.L. Grantham, C.C. Kerr, D.P. Wilson. (2016)

AIDS, 30(9):1481-1482 [PDF]

In the interests of time: improving HIV allocative efficiency modeling via optimal time-varying allocations

A.J. Shattock, C.C. Kerr, R.M. Stuart, E. Masaki, N. Fraser, C. Benedikt, M. Gorgens, D.P. Wilson, R.T. Gray. (2016)

J Int AIDS Society, 19:20627 [PDF]

Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies

Q.D. Pham, D.P. Wilson, T.V. Nguyen, N.T. Do, L.X. Truong, L.T. Nguyen, L. Zhang. (2016)

J Antimicrobial Chemotherapy, 71(5):1367-1379 [PDF]

The funding landscape for HIV in Asia and the Pacific

R.M. Stuart, E. Lief, B. Donald, D. Wilson, D.P. Wilson. (2015)

J Int AIDS Society, 18:20004 [PDF]

Sustainable HIV Treatment in Africa through Viral Load-Informed Differentiated Care

Working Group on Modelling of ART Monitoring Strategies in Sub-Saharan Africa (A. Phillips, A. Shroufi, L. Vojnov, J. Cohn, T. Roberts, T. Ellman, K. Bonner, C. Rousseau, G. Garnett, V. Cambiano, F. Nakagawa, D. Ford, L. Bansi-Matharu, A. Miners, J. Lundgren, J. Eaton, R. Parkes-Rotanshi, Z. Katz, D. Maman, N. Ford, M. Vitoria, M. Doherty, D. Dowdy, B. Nichols, M. Murtagh, M. Wareham, K. Palamountain, C.C. Musanhu, W. Stevens, D. Katzenstein, A. Ciaranello, R. Barnabas, S. Braithwaite, E. Bendavid, K.J. Nathoo, D. van de Vijver, D. Wilson, C. Holmes, A. Bershteyn, S. Walker, E. Raizes, I. Jani, L. Nelson, R. Peeling, F. Terris-Prestholt, J. Murungu, T. Mutasa-Apollo, T. Hallett, P. Revill). (2015)

Nature, 7580(528):S68-S76 [PDF]

Can we know in advance whether models will get it right?

D.P. Wilson, C.C. Kerr. (2015)

The Lancet Global Health, 3(10):e577-578 [PDF]

Re-orienting the HIV response in Niger towards sex work interventions: from better evidence to targeted and expanded practice

Fraser N, Kerr CC, Harouna Z, Alhousseini Z, Cheikh N, Gray R, Shattock A, Wilson DP, Haacker M, Shubber Z, Masaki E, Karamoko D, Görgens M (2015)

JAIDS, 68:S213–S220 [PDF]

Scaling up HIV treatment for MSM in Bangkok: what does it take? -- a modelling and costing study

Zhang L, Phanuphak N, Henderson K, Nonenoy S, Srikaew S, Shattock A, Kerr CC, Omune B, van Griensven F, Sutayut Osornprasop S, Robert Oelrichs R, Ananworanich J, Wilson DP (2015)

Lancet HIV, 2:e200–07 [PDF]

Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization

Kerr CC, Stuart RM, Gray RT, Shattock A, Fraser-Hurt N, Benedikt C, Haacker M, Berdnikov M, Mahmood AM, Jaber SA, Gorgens M, Wilson DP (2015)

JAIDS, 69(3): 365-376 [PDF]

The cost-effectiveness of harm reduction

D.P. Wilson, B. Donald, A.J. Shattock, D. Wilson, N. Fraser-Hurt. (2015)

Int J Drug Policy, 26(S1):S5-S11 [PDF]

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JAC, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bärnighausen T, Bershteyn A, Bloom DE, Boily M-C, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DAMC, Wagner BG, White RG, Wilson DP, Zhang L, Bandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Easterbrook P, Hirnschall G, Hallett TB (2014)

The Lancet Global Health 2:e23-34 [PDF] [appendix]

Cost-effectiveness of antiretroviral therapy expansion strategies in Vietnam

D.A. Tran, D.P. Wilson, L. Zhang, A. Shakeshaft, A.D. Ngo, C. Doran. (2014)

AIDS Patient Care and STDs, Jul;28(7):365-71 [PDF]

Reply to PrEP cost-effectiveness

K. Schneider, R.T. Gray, D.P. Wilson. (2014)

Clinical Infectious Diseases, 59 (1):141 [PDF]

Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations

A.P. Craig, H.H. Thein, L. Zhang, R.T. Gray, K. Henderson, D. Wilson, M. Gorgens, D.P. Wilson. (2014)

Journal of the International AIDS Society, 17:18822 [PDF]

How should HIV programmes respond to evidence for the benefits of earlier treatment initiation? A combined analysis of twelve mathematical models

J.W. Eaton, N.A. Menzies, J. Stover, V. Cambiano, L. Chindelevitch, A. Cori, J.A.C. Hontelez, S. Humair, C.C. Kerr, D.J. Klein, S. Mishra, K.M. Mitchell, B.E. Nichols, P. Vickerman, R. Bakker, T. Bärnighausen, A. Bershteyn, D.E. Bloom, M.-C. Boily, S.T. Chang, T. Cohen, P.J. Dodd, C. Fraser, C. Gopalappa, J. Lundgren, N.K. Martin, E. Mikkelsen, E. Mountain, Q.D. Pham, M. Pickles, A. Phillips, L. Platt, C. Pretorius, H.J. Prudden J.A. Salomon, D.A.M.C. van de Vijver, S.J. de Vlas B.G. Wagner, R.G. White, D.P. Wilson, L. Zhang, J. Blandford, G. Meyer-Rath, M. Remme, P. Revill, N. Sangrujee, F. Terris-Prestholt, M. Doherty, N. Shaffer, P.J. Easterbrook, G. Hirnschall, T.B. Hallett (2014)

Lancet Global Health, 2:e23-34 [PDF]

Predicting the population impact of increased HIV testing and treatment in Australia

J. Jansson, C.C. Kerr, D.P. Wilson. (2014)

Sexual Health, 11:146–154 [PDF]

A cost-effectiveness analysis of HIV pre-exposure prophylaxis for men who have sex with men in Australia

K. Schneider, R.T. Gray, D.P. Wilson. (2013)

Clinical Infectious Diseases, 58(7):1027-1034 [PDF]

HIV service capacity: identifying current and future areas of clinical shortage

K.A. Mallitt, J. Jansson, H. Wand, L. Crooks, D.P. Wilson. (2013)

Sexual Health, 11(1):17-23 [PDF]

HIV antiretroviral prophylaxis for injecting drug users

A.P. Craig, R. Gray, J. Jansson, D.P. Wilson. (2013)

The Lancet, 382:854-855 [PDF]

The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa

K. Schneider, C. Nwizu, R. Kaplan, J. Anderson, D.P. Wilson, S. Emery, D.A. Cooper, M.A. Boyd. (2012)

PLoS One, 8(2):e54435 [PDF]

Understanding the modes of transmission model of new HIV infection and its use in prevention planning

K.K. Case, P.D. Ghys, E. Gouws, J.W. Eaton, A. Borquez, J. Stover, P. Cuchi, L.J. Abu-Raddad, G.P. Garnett, T.B. Hallett on behalf of the HIV Modelling Consortium (R. Atun, B. Auvert, N. Bacaer, T. Barnighau¬sen, A. Bershteyn, M.-C. Boily, W. Delva, P. Eckhoff, A. Foss, J. Heijne, D.J. Klein, N. Low, C.M. Lowndes, S. Mishra, C. Pretorius, A. Welte, P. White, B. Williams, D. Wilson, D.P Wilson, B. Zaba, H. Prudden). (2012)

Bulletin of the World Health Organization, 90:831-838

Demand for HIV clinical services is increasing in Australia but supply is decreasing

K.A. Mallitt, J. Jansson, L. Crooks, D. McGuigan, H. Wand, D.P. Wilson. (2012)

Sexual Health, 10(1):43-46 [PDF]

HIV Treatment as Prevention: Models, Data, and Questions toward Evidence-Based Decision-Making

The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (T. Barnighausen, S. Becker, E. Bendavid, A. Bershteyn, J. Blandford, M.-C. Boily, D. Burns, V. Cambiano, M.S. Cohen, I. Cremin, W. Delva, C. Dye, J.W. Eaton, M. Egger, C. Fraser, N. Galai, G. Garnett, P.D. Ghys, T.B. Hallett, L. Heaton, C.B. Holmes, J. Hontelez, B. Jewell, O. Keiser, D. Klein, V. Lima, E. Long, R. Lyerla, C. Marais, F. Meng, G. Meyer-Rath, W.C. Miller, N. Muraguri, B.E. Nichols, K.R. Nigmatulina, M. Over, N. Padian, A. Phillips, C. Pretorius, C. Rousseau, J. Salomon, N. Sangrujee, D. Serwadda, F. Tanser, J.F. Vesga, P. Vickerman, D. Walker, R. Wang, A. Welte, R.G. White, B. Williams, D.P. Wilson, D. Wilson, B. Zaba). (2012)

PLoS Medicine, 9(7):e1001259 [PDF]

Estimating the cost-effectiveness of needle-syringe programs in Australia.

Kwon JA, Anderson J, Kerr CC, Thein H-H, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson D (2012)

AIDS 26(17):2201-10 [PDF] [appendix]

Projected demographic profile of people living with HIV in Australia: planning for an older generation

J. Jansson, D.P. Wilson. (2012)

PLoS One, 7(8):e38334 [PDF]

HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling For Public Health Decision-Making in All Modes of Prevention and Evaluation

W. Delva, D.P. Wilson, L. Abu-Raddad, M. Gorgens, D. Wilson, T.B. Hallett, A. Welte. (2012)

PLoS Medicine, 9(7):e1001239 [PDF]

HIV Treatment as Prevention: Natural experiments highlight limits of antiretroviral treatment as HIV prevention

D.P. Wilson. (2012)

PLoS Medicine, 9(7):e1001231 [PDF]

Expected epidemiological impacts of introducing an HIV vaccine in Thailand: a model-based analysis

K. Schneider, C.C. Kerr, A. Hoare, D.P. Wilson. (2011)

Vaccine, 29:6086-6091 [PDF]

Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia

R.T. Gray, M.H. Ghaus, A. Hoare, D.P. Wilson. (2011)

Vaccine, 29:6125-6129 [PDF]

Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings

K. Schneider, T. Puthanakit, S. Kerr, M.G. Law, D.A. Cooper, B. Donovan, N. Phanuphak, V. Sirisanthana, J. Ananworanich, J. Ohata, D.P. Wilson. (2011)

AIDS, 25:1143-1151 [PDF]

How low can you go: The impact of a modestly effective HIV vaccine compared with male circumcision

J.M. Kaldor, D.P. Wilson. (2010)

AIDS, 24:2573-2578 [PDF]

An HIV epidemic is ready to emerge in the Philippines

A.C. Farr, D.P. Wilson. (2010)

Journal of the International AIDS Society, 13:16 [PDF]

What impact might the economic crisis have on HIV epidemics in Southeast Asia?

R.T. Gray, K.J. Heymer, A. Hoare, J.A. Kwon, H.H. Thein, N. Lote, P. Siba, S. Saramony, V. Saphonn, H. Worth, J.M. Kaldor, D.P. Wilson. (2009)

Current HIV Research, 7:656-665 [PDF]

Cost-effectiveness of adult circumcision for HIV prevention in men who have sex with men in a resource-rich setting

J.S. Anderson, D.P. Wilson, D.J. Templeton, A.E. Grulich, R. Carter, J.M. Kaldor. (2009)

Journal of Infectious Disease, 200:1803-1812 [PDF]

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis

J.A. Kwon, J. Iversen, L. Maher, M.G. Law, D.P. Wilson. (2009)

J AIDS, 51(4):462-469 [PDF]

Relation between HIV viral load and infectiousness? A model-based analysis

D.P. Wilson, M.G. Law, A.E. Grulich, D.A. Cooper, J.M. Kaldor. (2008)

The Lancet, 372:314-20 [PDF]

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics

D.P. Wilson, P.M. Coplan, M.A. Wainberg, S.M. Blower. (2008)

PNAS, 105(28):9835-40 [PDF]

Mathematical models and health economic aspects of microbicides

D.P. Wilson, P.M Coplan. (2008)

Current Opinion in HIV and AIDS, 3:587-592 [PDF]

Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria, and Queensland: the importance of other STIs

A. Hoare, D.P. Wilson, D.G. Regan, J. Kaldor, M.G. Law. (2008)

Sexual Health, 5:169-187 [PDF]

How far will we need to go to reach HIV-infected people in rural South Africa?

D.P. Wilson, S.M. Blower. (2007)

BMC Medicine, 5(1), 16 [PDF]

Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: The effect of the urban-rural divide

D.P. Wilson, J.O. Kahn, S.M. Blower. (2006)

PNAS, 103(38):14228-14233 [PDF]

Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency and feasibility

D.P. Wilson, S.M. Blower. (2006)

PLoS Medicine, 3(3), e160 [PDF]

Allocating Antiretrovirals in South Africa: Using Modeling to Determine Treatment Equity

D.P. Wilson, S.M. Blower. (2005)

PLoS Medicine, 2(6):563-564 [PDF]

Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries

D.P. Wilson, S.M. Blower. (2005)

PLoS Medicine, 2(2):132-141 [PDF]

Book chapters

The not-so-black box: Optima HIV methodology and approach. In Tackling the world’s fastest growing HIV epidemic: Gateways to efficient and effective HIV responses in Eastern Europe and Central Asia.

C.C. Kerr, R.M. Stuart, D.J. Kedziora, A. Brown, R. Abeysuriya, G.L. Chadderdon, A. Nachesa, D.P. Wilson. (2017)

The World Bank, Washington DC, USA

The next generation of decision science analytics: Optima. In Tackling the world’s fastest growing HIV epidemic: Gateways to efficient and effective HIV responses in Eastern Europe and Central Asia

D.P. Wilson, M. Gorgens. (2017)

The World Bank, Washington DC, USA

See the bigger picture: Resource optimization tools to inform HBP design. In What’s In, What’s Out? Designing Benefits for Universal Health Coverage, pp. 214-233

M. Gorgens, J. Petravic, D.J. Wilson, D.P. Wilson. (2017)

Center for Global Development, Washington DC, USA

Technical Reports

Eliminating Viral Hepatitis – The Investment Case: Report of the WISH Viral Hepatitis Health Forum 2018

M. Hellard, A. Pedrana, J. Howell, S. Schroeder, N. Scott, C. Kuschel, D. Wilson

[Coming soon]

National HIV Allocative Efficiency Analysis in Mexico

C. Gutiérrez, F. Lavadenz, C. Macías, J. Petravic, L. Lavadenz (2018)

The World Bank Group [PDF]

Optimizando la Inversión del Plan de Respuesta de Colombia al VIH

C. Gutiérrez, R.M. Stuart, D.P. Wilson, F. Lavadenz, I. Reporter, C. Kerr (2018)

The World Bank Group [PDF]

Allocative Efficiency Analysis (HIV) 2015-2030 for Karnataka & Punjab — India

Public Health Foundation of India in collaboration with National AIDS Control Organisation, National Institute of Medical Statistics, and Burnet Institute (2017)

The World Bank [PDF]

Optimizing investments in Belarus’ tuberculosis response

(2017)

The World Bank for the Government of Belarus [PDF]

Improving the allocative efficiency of Malawi’s HIV response: findings from a mathematical modeling analysis

C.C. Kerr, C. Benedikt (2017)

The World Bank [PDF]

Model-based cost-effectiveness and impact assessment of needle-syringe programs in Ontario, Canada from 2006–2015

S.L. Kelly, X.F. Yap, S, Hainsworth, R.M. Stuart, D.P. Wilson (2017)

Technical Report for the Ministry of Health, Ontario, Canada [PDF]

Allocating HIV funding efficiently in Myanmar: analyses using the Optima HIV model

J. Estill, Z. Barańczuk, I. Reporter, D. Wilson, K. Boonto, S. Osornprasop, E. Masaki, J. de Beyer (2017)

The World Bank [PDF]

Optimización de las inversiones para la respuesta al VIH en Perú

L. Prieto, V. Montañez, J. Petravic, I. Reporter, A. Medici (2017)

The World Bank Group [PDF]

National HIV Allocative Efficiency Analysis in Argentina

N. Calvo, F. Lavadenz, I. Reporter, J. Petravic, C. Pantanali, C. Lavadenz (2017)

The World Bank Group [PDF]

Ending AIDS in Johannesburg: An analysis of the status and scale-up towards HIV treatment and prevention targets.

Burnet Institute, Optima Consortium for Decision Science (2016)

The World Bank for the Gauteng Province Department of Health and South African Department of Health [PDF]

Optimizing Investments in Togo’s HIV Response

University College London, Burnet Institute, University of New South Wales (2016)

The World Bank for the Government of Togo [PDF]

HIV investment in Senegal: Optimized allocation of HIV resources for a sustainable and efficient HIV response

University of Bern, University of New South Wales, Burnet Institute, and The World Bank (2016)

The World Bank [PDF]

HIV Investment in Cote d’Ivoire: Optimized allocation of HIV resources for a sustainable and efficient HIV response

University of Bern, University of New South Wales, Burnet Institute, and The World Bank (2016)

The World Bank [PDF]

Optimizing investments in Bulgaria’s HIV response.

University College London, Burnet Institute, University of New South Wales (2016)

The World Bank, Global Fund, UINAIDS, and UNDP for the Government of Bulgaria [PDF]

Optimizing investments in Belarus for the National HIV Response

O. Atroshchanka, A. Fisenka, V. Ilyenkova, P. Đurić, R. Gray, C. Benedikt, E. Masaki, M. Obst, D. Kokiashvili, C. Maxim, G. Sakvarelidze, S. Zhang, R. Hailevich, M. Manova, C. Hamelmann, C. Kerr, R. Stuart, D.P. Wilson, M. Görgens, S.N. Nguyen, D. Wilson (2016)

The World Bank Group [PDF]

Optimizing Investments in the Kyrgyz Republic’s HIV Response

V. Maitieva, L. Ianbukhtina, T. Mambetov, L. Bashmakova, M. Sarybaeva, P. Đurić, A. Shattock, C. Benedikt, E. Masaki, M. Obst, D. Soorombaeva, A. Abarbekova, M. Kazizova, S. Irbe, D. Kokiashvili, N. Mdivani, S. Zhang, R. Hailevich, M. Manova, O. Scutelniciuc, C. Hamelmann, J. Macauley, R. Stuart, C. Kerr, D.P. Wilson, R. Patel, S.N. Nguyen, M. Görgens (2016)

The World Bank Group [PDF]

Value for money in Ukraine’s HIV response: strategic investment and improved efficiency

I. Kuzin, K. Sharapka, E. Gvozdeva, C. Kerr, R. Stuart, E. Masaki, A. Goroshko, C. Benedikt, N. Nizova, D.P. Wilson, J. Boyko, P. Belli, M. Görgens, D. Wilson, M. Manova, R. Hailevich, J. Tyszko, P. Đurić, C. Hamelmann, S. Zhang, G. Sakvarelidze, M. Görgens, P. Belli, O. Doroshenko, N. Fraser, R.R. Garcia, Z. Shubber (2016)

The World Bank Group [PDF]

Optimizing Investments in Georgia’s HIV Response

A. Asatiani, D. Baliashvili, I. Khonelidze, E. Ruadze, K. Stvilia, M. Tsereteli, O. Chokoshvili, H. Haghparast-Bidgoli, L. Grobicki, J. Panovska-Griffiths, J. Skordis-Worrall, C. Benedikt, C.C. Kerr, R.M. Stuart, D.P. Wilson, M. Görgens, E. Masaki, R. Hailevic, M. Manova, D. Kokiashvili, D. Loncar, T. Sakanyan, S. Zhang, P. Đurić, C. Hamelmann (2016)

The World Bank Group [PDF]

Optimizing HIV Investments in Armenia

S. Grigoryan, T. Grigoryan, R. Hovhannisyan, A. Papoyan, S. Kelly, C. Benedikt, D.F. Cuadros, E. Masaki, M. Obst, V. Grishechkina, D. Kokiashvili, S. Zhang, R. Hailevich, M. Manova, P. Đurić, C. Hamelmann, C. Kerr, R. Stuart, D.P. Wilson, S.N. Nguyen, M. Görgens, W. Heard (2016)

The World Bank Group [PDF]

Optimizing investments in Kazakhstan’s HIV response

B.S. Baiserkin, A. Bokazhanova, L.U. Ganina, N.F. Kalinich, A.A. Kazimova, I.I. Petrenko, A.V. Yelizarieva, P. Đurić, A. Shattock, C. Benedikt, E. Masaki, M. Obst, N. Farcy, D. Kokiashvili, T. Vinichenko, S. Zhang, R. Hailevich, M. Manova, O. Scutelniciuc, C. Hamelmann, C.C. Kerr, R.M. Stuart, D.P. Wilson, S.N. Nguyen, M. Görgens, D. Wilson, R. Patel, M. Bortman, B. Zhumadil (2016)

The World Bank Group [PDF]

Science addressing drugs and HIV: State of the Art: 2nd Scientific Statement

D. Des Jarlais, F. Bastos, C. Benedikt, J. Feelemyer, K. Hayashi, S. Kelly, T. Kerr, H. Lim, J. Loh, M.-J.S. Milloy, S. Shoptaw, A. Williams, D.P. Wilson, D. Wilson, M. Beg, F. Hariga (2016)

UNODC [PDF]

Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs

D. Wilson, C. Benedikt, S. Kelly. D.P. Wilson. (2016)

UNODC Science Addressing Drugs and HIV: State of the Art Scientific Consensus for High Level Segment of the 59th session of the Commission on Narcotic Drugs [PDF]

Optimizing Investments in the National HIV Responses of Indonesia and Thailand: a Report for World Health Organization South-east Asia Regional Office

Grantham K, Reagan D, Law M, Wilson DP (2016)

WHO [PDF ]

Optimizing Investments in Moldova’s HIV Response

University of New South Wales, Burnet Institute (2015)

The World Bank, Global Fund, UNAIDS, and UNDP for the Government of Moldova [PDF]

Optimizing investments in Former Yugoslav Republic of Macedonia’s HIV response

University College London, Burnet Institute, University of New South Wales (2015)

The World Bank for the Government of FYR Macedonia [PDF]

Modelling an Optimised Investment Approach for Uzbekistan: sustainable financing of National HIV responses

D.P. Wilson, C. Kerr, P. Đurić, C. Hamelmann (2015)

UNDP for the Republic of Uzbekistan [PDF]

Zambia’s HIV Response: Prioritized and strategic allocation of HIV resources for impact and sustainability (findings from the HIV allocative efficiency study)

Masaki E, Fraser N, Haacker M, Obst M, Wootton R, Sunkutu R, Gorgens M, Gray RT, Shattock A, Kerr CC, Wilson DP (2015)

The World Bank and UNSW Australia for the Government of Zambia [PDF] [Supplementary]

Investing for Results: How Asia Pacific countries can invest for ending AIDS. High-level panel for AIDS Funding Landscape in Asia and the Pacific

A. Shattock, R. Gray, B. Donald, R. Stuart, E. Lief, L. Zhang, D. Wilson (2015)

Released at UNESCAP 2015, Bangkok. Comments by International AIDS Economics Network [PDF]

Sudan’s HIV response: Value for money in a low-level HIV epidemic; Findings from the HIV allocative efficiency study

Fraser N, Benedikt C, Obst M, Masaki E, Gorgens M, Stuart R, Shattock A, Gray RT, Kerr CC, Wilson DP (2014)

The World Bank and UNSW Australia [PDF]

Optimizing allocation of resources for HIV/AIDS responses: presented to the United Nations General Assembly

D.P. Wilson, R. Stuart, A. Shattock, R. Gray, S. Kelly (New York, September 2014)

UNAIDS World AIDS Day report (page 36) [PDF]

HIV Mathematical Modelling to Support Swaziland's Development of its HIV Investment Case

Kelly S, Shattock A, Kerr CC, Gama T, Nhlabatsi N, Zagatti G, Harimurti P, Wilson DP, Gorgens M (2014)

The World Bank Group and UNSW for the Government of Swaziland [PDF]

HIV resource needs, availabilities and gaps across ASEAN countries

D.P. Wilson, A. Shattock, R. Gray. (Hanoi, Vietnam; September 2014)

presented to the ASEAN Health Ministers Summit [PDF]

Niger’s HIV response: Targeted investments for a health future. Findings from the HIV allocative efficiency and financial sustainability study

Fraser N, Cheikh N, Haacker M, Masaki E, Karamoko D, Gorgens M, Frescura L, Konan C, Kerr CC, Gray RT, Shattock A, Wilson DP (2014)

The World Bank [PDF-English] [PDF-Français]

Ukraine HIV Program Efficiency Study: Can Ukraine improve value for money in HIV service delivery?

D.P. Wilson, K. Razali, K. Henderson, L. Maher, J. Ellard, A. Shattock, I. Semini, E. Masaki, M. Gorgens. (2014).

The World Bank [PDF]

Return on Investment and Cost-Effectiveness of Harm Reduction Programmes in Malaysia

Naning H, Kerr CC, Kamarulzaman, Dahlui AM, Ng CW, Wilson DP (2014)

The World Bank [PDF]

HIV Investment in Armenia: Analysis & Recommendations

Kerr CC, Wilson DP (2014)

UNAIDS [PDF]

Modelling an optimized investment approach for Tajikistan

Duric P, Hammelmann C, Wilson DP, Kerr CC (2014)

UNDP [PDF-English] [PDF-русский]

Evaluation of a Decade of DFID and World Bank Supported HIV and AIDS Programmes in Vietnam from 2003 to 2012

Zhang L, Maher L, Pham DQ, Higgs P, Anh ND, Duc BH Shattock A, Hoa DM, Wilson DP (2014)

The World Bank [PDF]

Effectiveness and cost-effectiveness of harm reduction. UNODC Science Addressing Drugs and HIV: State of the Art Scientific Consensus for High Level Segment of the 55th session of the Commission on Narcotic Drugs.

D.P. Wilson. (2013)

UNODC [PDF]

HIV Resource Needs, Efficient Allocation and Resource Mobilization for the Republic of Belarus

Wilson DP, Yakusik A, Kerr CC, Avila C (2013)

UNAIDS and UNDP [PDF]

Return on Investment of Needle-Syringe Programs in the Philippines

Wilson DP, Reyes J, Kerr CC, Gray RT (2013)

The World Bank [PDF]
[Policy brief]

Return on Investment of HIV Prevention in Vietnam

Zhang L, Pham QD, Do MH, Kerr CC, Wilson DP (2012)

The World Bank [PDF]

Assessment of the allocation of HIV funding in Indonesia.

R.T. Gray, J. Reyes, M. Nadjib, P. Harimurti, D.P. Wilson (2012)

The World Bank [PDF]

The cost-effectiveness of needle-syringe exchange programs in Eastern Europe and Central Asia: costing, data synthesis, modeling and economics for eight case study countries

D.P. Wilson, L. Zhang, C.C. Kerr, A. Uusküla, J.A. Kwon, A. Hoare, K. Sharapka, T. Balabayev, A. Yakusik, E. Gvozdeva, G. Ionascu, D. Otiashvili, T. Grigoryan, A. Soliev, M. Williams-Sherlock, C. Avila on behalf of the Technical Working Group to evaluate the cost-effectiveness of needle-syringe exchange programs in Eastern Europe and Central Asia (2012)

UNAIDS Technical Report, Geneva, Switzerland [PDF]
[Supplementary Material]

The Papua New Guinea HIV Model: explaining the past, describing the present, and forecasting the future of the HIV epidemic in PNG

R.T. Gray, J.M. Murray, D.P. Wilson, A. Vallely, J. Kaldor. (2011)

The Kirby Institute, The University of New South Wales [PDF]
[Technical Appendix]
[Software Manual]

Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam

D.P. Wilson, V. Loo, L. Zhang, H.H. Thein, R. Gray, A. Kwon. (2011)

Vietnam Administration for HIV/AIDS Control and The World Bank [PDF]

The HIV in Indonesia Model (HIM)

D.P. Wilson, P. Riono, C. Kerr, A. Kwon, L. Zhang, J. Kaldor, A. Sutrisna, M.N. Farid, N. Hadi. (2011)

University of Indonesia [PDF]
[Software Manual]

Epidemiology and modeling report on HIV/AIDS in the Philippines

A.C. Farr, D.P. Wilson. (2010)

Technical Report for the World Bank [PDF]

Economic evaluation of potential increased hepatitis C treatment uptake in Australia

R. Thein, A. Hoare, D. Wilson, M. Krahn, G. Dore, A. Kwon, J. Iversen, L. Maher. (2010)

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales [PDF]

Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs among injecting drug users in Australia

D. Wilson, J. Kwon, J. Anderson, H.H. Thein, M. Law, L. Maher, G. Dore, J. Kaldor. (2009)

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales [PDF]

Evaluation of the potential impact of the global economic crisis on HIV epidemics in Southeast Asia (prepared for AusAID)

D.P. Wilson, R. Gray, K.J. Heymer, A. Hoare, J. Kwon, H.H. Thein, H. Worth, J. Kaldor. (2009)

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales [PDF]

Mathematical models to investigate recent trends in HIV notifications among men who have sex with men in Australia

D.P. Wilson, A. Hoare, D.G. Regan, H. Wand, M.G. Law. (2008)

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales [PDF]

Copyright © 2018 by the Optima team. Terms and Conditions